GlaxoSmithKline Inc.

GlaxoSmithKline Inc.

SmithKline Beecham Pharma is one of the largest innovative
pharmaceutical companies in the world. The mandate of the
pharmaceutical organization is health care, defined as the
prevention, prediction, diagnosis, treatment, and cure. As
one of Canada's fastest growing pharmaceutical companies,
SmithKline Beecham has increased its workforce by over 33 percent
in the past 3 years, and we plan to add even more people to the
SB Team. Since the passage of Bill C-91 for Patent Protection in
1993, the ratio of Research & Development to Sales for SmithKline
Beecham Parma has been 10.9 percent. We're proud to have one of
the most active pipelines in the industry and expect to bring
several new products to market each year for the next five years.
In 1996 alone, we brought three new products to market : Kytril,
Coreg, and Famvir. SmithKline Beecham Pharma is the world's
largest vaccine supplier, producing Havrix and Enfgerix-B for
hepatitis A and hepatitis B respectively. SB Pharma recently
launched the first combined hepatitis A and B vaccine, Twinrix.

Vision
SmithKline Beecham must be an active participant in the health
reform debate. We believe an optimal health care system can be
achieved through appropriate use of all components. Our role is
to ensure the right drug is used at the right time and for the
right indication to make our drug programs viable and effective.
In doing so, we maximize therapeutic outcomes, increase quality
of life, and minimize costs.

A Caring Company
-SmithKline Beecham Pharma Canada is recognized as A
Caring Company by the Canadian Centre for Philanthropy in honour
of our long-standing commitment to re-investing a significant
percentage of profits into Canadian charitable and not-for-profit
community organizations. We believe it's our corporate
responsibility to improve the quality of life communities where
we work and conduct business.
-SB has twice won the Town of Oakville's Mayor's Award for
charitable community giving.
-In 1996, we received recognition by the Speaker of the
House of Commons Gilbert Parent for our lifesaving product
donations to Map International.

Partnerships
The health care industry globally, as in our own country, is
facing difficult challenges. But these challenges also represent
great opportunities. Our products, expertise, financial
resources and most importantly, our people are an exceptional
base for building sound partnerships for Canada's future.

SB Pipeline & Economic Investment for Canada
SmithKline Beecham Pharma will continue to be a major player in
the pharmaceutical industry as indicated by the following
inventory of our product pipeline. These innovative
pharmaceuticals will require continuing our investment in
research and development as we bring these drug therapies to
market.

A list of our products :
Paxil- treatment for depression, particularly effective when
accompanied by symptoms of anxiety

Relafen- treatment of osteo and rheumatoid arthritis

Engerix-B - treatment for the prevention of Hepatitis B

Havrix- the world's first vaccine for Hepatitis A

Famvir- anti-viral for treatment of herpes

Kytril- treatment for chemotherapy induced nausea and vomiting

Coreg- significant improvement for treatment of congestive heart
failure with 65% reduction in mortality. * COREG is a trademark
of Boehringer Mannhein used under licence by SmithKline Beecham
Inc.

Hycamtin- second-line agent for treatment of patients with
ovarian cancer

Requip- treatment for patients in the early stages of
Parkinson's disease and as adjunct therapy for those in later
stages.

Please note : SB Pharma does not manufacture in Canada.

Company Details

Number of Employees: 286

Company Information

Flora De Mintich
Title: Sales Contract Specialist
Telephone: (905) 829-2030
Fax: (905) 829-6065

Pamela K. Dicenzo
Title: Director
Area of Responsibility: Management Executive
Telephone: 905 829230

Rhonda Hustler
Telephone: (905) 829-2030
Fax: (905) 829-6076

Products

Drug Research

Research Programs
Current research programs within each of the key therapeutic areas CARDIOPULMONARY - Hypertension - Myocardial salvage / ischaemia - Atherosclerosis - Asthma - Chronic obstructive pulmonary disease - Congestive heart failure - Cerebrovascular disease / stroke - Diabetes VACCINES - Hepatitis C and E - Lyme disease - Influenza - Herpes - Malaria - Cancer - therapeutic vaccines NEUROSCIENCES - Epilepsy - Anxiety - Depression - Schizophrenia - Migraine - Alzheimer's disease ANTI-INFECTIVES AND BIOLOGICALS - Antibacterials - Antivirals - Antifungals - Haematopoiesis INFLAMMATION / TISSUE REPAIR / ONCOLOGY - Chronic inflammation including osteoarthritis - Auto-immune disease including rheumatoid arthritis - Prostatic disease - Osteoporosis - Cancer

Services